Abstract
The treatment of juvenile idiopathic arthritis has improved tremendously in the past 20 years as a result of appropriate legislative initiatives, large international collaborative networks, and the availability of new potent medications. Despite these considerable advances, a sizable proportion of patients are still resistant to treatment. Further improvement will stem from a better definition of the disease entities under the broad term juvenile idiopathic arthritis (which includes all forms of arthritis with disease onset before the age of 16 years); the discovery of laboratory and imaging biomarkers that could help the tuning of therapy; smoother implementation of clinical trials; more standardised links between academia, regulatory authorities, and patient organisations for the planning of future trials; and the availability of new drugs that selectively target molecules or pathways involved in inflammation.
Citations
May 30, 2020·International Journal of Molecular Medicine·Na HuangXiaoyu Zhou
Jun 12, 2020·Nanoscale·Nadim AhamadRinti Banerjee
Jun 14, 2020·Pediatric Rheumatology Online Journal·Mona DaveHelen E Foster
Oct 9, 2020·Paediatric Drugs·Hermine I BrunnerUNKNOWN Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group
Nov 26, 2020·Clinical Rheumatology·Kai Liang TehThaschawee Arkachaisri
Aug 13, 2020·Arthritis & Rheumatology·Pierre QuartierUNKNOWN Paediatric Rheumatology International Trials Organisation and the Pediatric Rheumatology Collaborative Study Group
Jan 17, 2021·Pharmaceutical Medicine·Klaus RoseEarl B Ettienne
Jan 26, 2021·Rheumatology·Nicolino RupertoUNKNOWN Pediatric Rheumatology Collaborative Study Group (PRCSG) and the Paediatric Rheumatology International Trials Organisation (
Mar 9, 2021·Current Rheumatology Reports·Gabriella GiancaneNicolino Ruperto
Mar 19, 2021·Nature Reviews. Rheumatology·Peter A NigrovicAlberto Martini
Mar 27, 2021·Pediatric Rheumatology Online Journal·Tatjana WelzelMarc Pfister
Aug 3, 2021·Frontiers in Molecular Biosciences·Min ZhangXiaodong Zhao
Aug 25, 2021·Pediatric Rheumatology Online Journal·Lina N ZaripovaRachel A Oldershaw
Aug 27, 2021·BMC Oral Health·Elisabeth G GilMarit S Skeie
Jul 18, 2021·Rheumatology·Ilaria MaccoraGabriele Simonini
Jan 29, 2022·Nature Reviews. Disease Primers·Alberto MartiniNicolino Ruperto